메뉴 건너뛰기




Volumn 26, Issue 2, 2005, Pages 359-361

New intralesional therapy for basal cell carcinoma by 2% zinc sulphate solution

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; LIDOCAINE; ZINC SULFATE;

EID: 17144408330     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (6)

References (5)
  • 3
    • 0030782329 scopus 로고    scopus 로고
    • A comparative controlled trial of intralesionally administered zinc sulphate, hypertonic solution chloride and pentavalen antimony compounds against a case cutaneous leishmaniasis
    • Sharquie KE, Najim RA, Farjou IB. A comparative controlled trial of intralesionally administered zinc sulphate, hypertonic solution chloride and pentavalen antimony compounds against a case cutaneous leishmaniasis. Clin Exp Dermatology 1997; 22: 169-173.
    • (1997) Clin. Exp. Dermatology , vol.22 , pp. 169-173
    • Sharquie, K.E.1    Najim, R.A.2    Farjou, I.B.3
  • 4
    • 0036056341 scopus 로고    scopus 로고
    • Treatment of viral warts by intralesional injection of zinc sulphate
    • Sharquie KE, Al-Nuaimy AA. Treatment of viral warts by intralesional injection of zinc sulphate. Ann Saudi Med 2002; 22: 26-28.
    • (2002) Ann. Saudi Med. , vol.22 , pp. 26-28
    • Sharquie, K.E.1    Al-Nuaimy, A.A.2
  • 5
    • 0003609171 scopus 로고    scopus 로고
    • World Health Organization. Geneva: WHO
    • World Health Organization. Zinc: Environmental Health Criteria. Geneva: WHO; 2001. p. 250.
    • (2001) Zinc: Environmental Health Criteria , pp. 250


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.